CCR3
C-C chemokine receptor type 3 (CCR3, CD193) is a seven-transmembrane G protein-coupled receptor specializing in eosinophil trafficking and activation, earning its designation as the principal eosinophil chemokine receptor. Its ligand portfolio includes CCL11 (eotaxin-1), CCL24 (eotaxin-2), CCL26 (eotaxin-3), CCL5, CCL7, CCL8 and CCL13, all binding with a hierarchy that allows eotaxins to dominate in eosinophil recruitment. CCR3 is abundantly expressed on eosinophils, basophils, mast cells and a subset of Th2 cells, coupling through Gαi to trigger chemotaxis, respiratory burst, adhesion molecule upregulation and mediator release. This receptor is central to allergic disease pathophysiology: it coordinates eosinophil accumulation in asthmatic airways, allergic rhinitis, atopic dermatitis and eosinophilic gastrointestinal disorders. CCR3 also functions as an HIV-1 co-receptor for certain R5/X4 dual-tropic strains. Small-molecule CCR3 antagonists and anti-eotaxin antibodies have been developed to interrupt eosinophil-driven inflammation, and airway CCR3 expression correlates with disease severity in asthma.